TRAVAGLINI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 1.385
EU - Europa 857
AS - Asia 812
SA - Sud America 73
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.144
Nazione #
US - Stati Uniti d'America 1.357
CN - Cina 272
SG - Singapore 266
IE - Irlanda 119
UA - Ucraina 109
GB - Regno Unito 99
SE - Svezia 99
IT - Italia 93
DE - Germania 92
TR - Turchia 92
RU - Federazione Russa 83
FR - Francia 73
VN - Vietnam 68
BR - Brasile 67
IN - India 45
FI - Finlandia 41
CA - Canada 20
BD - Bangladesh 8
CZ - Repubblica Ceca 8
HK - Hong Kong 8
JP - Giappone 8
PL - Polonia 8
CH - Svizzera 7
ES - Italia 6
MX - Messico 6
NL - Olanda 6
SA - Arabia Saudita 6
ZA - Sudafrica 5
BE - Belgio 4
IQ - Iraq 4
IR - Iran 4
JO - Giordania 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
EU - Europa 3
GR - Grecia 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
CL - Cile 2
ID - Indonesia 2
IL - Israele 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
TN - Tunisia 2
AU - Australia 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.144
Città #
Singapore 196
Chandler 165
Jacksonville 147
Dublin 119
San Jose 118
Ashburn 104
Dallas 92
Beijing 80
Southend 80
The Dalles 60
Princeton 54
Nanjing 50
New York 45
Izmir 39
Munich 31
Council Bluffs 30
Los Angeles 28
Dearborn 26
Ho Chi Minh City 25
Cambridge 24
Ann Arbor 21
Santa Clara 20
Hanoi 19
Moscow 19
Wilmington 19
Nanchang 18
Altamura 17
Tongling 17
Chieti 14
Grevenbroich 12
Washington 12
Turku 11
Frankfurt am Main 10
Montreal 10
Denver 9
Redondo Beach 9
Shenyang 9
São Paulo 9
Buffalo 8
Hong Kong 8
Norwalk 8
Torino 8
Brooklyn 7
Fermo 7
Guangzhou 7
Kunming 7
Tokyo 7
Warsaw 7
Amsterdam 6
Atlanta 6
Brno 6
Fribourg 6
Hangzhou 6
Monmouth Junction 6
Orem 6
Phoenix 6
Stockholm 6
Tianjin 6
Boardman 5
Camerino 5
Changchun 5
Changsha 5
Hebei 5
Helsinki 5
Amman 4
Ankara 4
Brussels 4
Jiaxing 4
Jinan 4
Lanzhou 4
Montesilvano Marina 4
Poplar 4
San Francisco 4
Toronto 4
Annapolis 3
Ardabil 3
Augusta 3
Baghdad 3
Belgrade 3
Chennai 3
Houston 3
Johannesburg 3
London 3
Mexico City 3
Mumbai 3
San Mateo 3
San Vito Chietino 3
Biên Hòa 2
Boston 2
Brasília 2
Campobasso 2
Caxias do Sul 2
Chicago 2
Concord 2
Curitiba 2
Da Nang 2
Dammam 2
Florence 2
Fortaleza 2
Hải Dương 2
Totale 2.037
Nome #
Cleavage of cystatin C is not associated with multiple sclerosis 167
Increasing age at disability milestones among MS patients in the MSBase Registry 153
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 148
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 141
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 141
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 140
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 136
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 136
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 134
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 134
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 126
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 125
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 123
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 122
JCV-Ab serostatus in MS patients treated with Natalizumab 121
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 116
Natalizumab-associated PML-IRIS: the Chieti experience. 113
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 109
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 106
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 96
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 96
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 93
New daily persistent headache after SARS-CoV-2 infection: a report of two cases 91
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 78
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 75
Totale 3.167
Categoria #
all - tutte 12.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022127 1 4 6 30 5 2 11 8 10 4 14 32
2022/2023418 29 66 27 35 48 78 21 30 63 5 8 8
2023/2024235 13 9 17 3 24 113 24 0 1 6 3 22
2024/2025462 30 34 46 7 8 22 16 18 30 30 110 111
2025/20261.013 88 24 121 151 121 45 169 39 115 78 50 12
Totale 3.167